BioCentury | Jul 16, 2001
Emerging Company Profile

Corporate Profile

Milagen Inc. Richmond, Calif. Technology: Antibiomix high throughput polyclonal antibody generation for all proteins in any organism Disease focus: Cancer, inflammatory and infectious diseases Clinical status: NA Founded: 1997 by Moncef Jendoubi Corporate partners: None...
BioCentury | Jul 16, 2001
Emerging Company Profile

Milagen: Antibodies, quick time

...but most of the attention for both reagent and therapeutic use has been on monoclonals. Milagen Inc....
...The company's goal is to create an antibody to every protein in the human proteome. Milagen's...
...polyclonals to any protein in just five weeks. According to founder and CEO Moncef Jendoubi, Milagen...
Items per page:
1 - 2 of 2
BioCentury | Jul 16, 2001
Emerging Company Profile

Corporate Profile

Milagen Inc. Richmond, Calif. Technology: Antibiomix high throughput polyclonal antibody generation for all proteins in any organism Disease focus: Cancer, inflammatory and infectious diseases Clinical status: NA Founded: 1997 by Moncef Jendoubi Corporate partners: None...
BioCentury | Jul 16, 2001
Emerging Company Profile

Milagen: Antibodies, quick time

...but most of the attention for both reagent and therapeutic use has been on monoclonals. Milagen Inc....
...The company's goal is to create an antibody to every protein in the human proteome. Milagen's...
...polyclonals to any protein in just five weeks. According to founder and CEO Moncef Jendoubi, Milagen...
Items per page:
1 - 2 of 2